CN Stock MarketDetailed Quotes

600566 Hubei Jumpcan Pharmaceutical

Watchlist

30.18
-0.03-0.10%

Market Closed Nov 1 15:00 CST

27.82BMarket Cap10.00P/E (TTM)

Hubei Jumpcan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Jumpcan Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 10.860B	--
--	2024/FY	-- / 10.042B	--
--	2023/FY	9.655B / 10.055B	--
--	2022/FY	8.996B / 8.582B	--
--	2021/FY	7.631B / 7.233B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 10.860B--

--2024/FY-- / 10.042B--

--2023/FY9.655B / 10.055B--

--2022/FY8.996B / 8.582B--

--2021/FY7.631B / 7.233B--

Unlock Free Earnings Estimates

Open Account

Hubei Jumpcan Pharmaceutical Earnings Reports

Hubei Jichuan Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

Oct 25 12:00 ET

Hubei Jumpcan Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

Aug 23 12:00 ET

Summary of the 2024 interim report of Hubei Jumpcan Pharmaceutical Co., Ltd.

Aug 23 12:00 ET

Hubei Jichuan Pharmaceutical Co., Ltd. Report for the first quarter of 2024

Apr 19 12:00 ET

Analyst Rating

Updated: Nov 3, 2024

Strong Buy

Strong Buy
80.00%
Buy
20.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall